These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27699241)

  • 1. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against
    El Bissati K; Chentoufi AA; Krishack PA; Zhou Y; Woods S; Dubey JP; Vang L; Lykins J; Broderick KE; Mui E; Suzuki Y; Sa Q; Bi S; Cardona N; Verma SK; Fraczek L; Reardon CA; Sidney J; Alexander J; Sette A; Vedvick T; Fox C; Guderian JA; Reed S; Roberts CW; McLeod R
    JCI Insight; 2016 Sep; 1(15):e85955. PubMed ID: 27699241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; El Bissati K; Zhou Y; Suzuki Y; Lee D; Woods S; Sommerville C; Henriquez FL; Roberts CW; McLeod R
    Hum Immunol; 2012 Jan; 73(1):1-10. PubMed ID: 22027386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
    Vaccine; 2011 Jan; 29(4):754-62. PubMed ID: 21095258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice.
    El Bissati K; Zhou Y; Dasgupta D; Cobb D; Dubey JP; Burkhard P; Lanar DE; McLeod R
    Vaccine; 2014 May; 32(26):3243-8. PubMed ID: 24736000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.
    Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
    Immunome Res; 2010 Dec; 6():12. PubMed ID: 21129215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice.
    El Bissati K; Zhou Y; Paulillo SM; Raman SK; Karch CP; Reed S; Estes A; Estes A; Lykins J; Burkhard P; McLeod R
    Sci Rep; 2020 Oct; 10(1):16984. PubMed ID: 33046728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
    Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
    Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein nanovaccine confers robust immunity against
    El Bissati K; Zhou Y; Paulillo SM; Raman SK; Karch CP; Roberts CW; Lanar DE; Reed S; Fox C; Carter D; Alexander J; Sette A; Sidney J; Lorenzi H; Begeman IJ; Burkhard P; McLeod R
    NPJ Vaccines; 2017; 2():24. PubMed ID: 29263879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
    Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
    Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.
    Tan TG; Mui E; Cong H; Witola WH; Montpetit A; Muench SP; Sidney J; Alexander J; Sette A; Grigg ME; Maewal A; McLeod R
    Vaccine; 2010 May; 28(23):3977-89. PubMed ID: 20347630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of
    Guo J; Zhou A; Sun X; Sha W; Ai K; Pan G; Zhou C; Zhou H; Cong H; He S
    Front Immunol; 2019; 10():592. PubMed ID: 30984177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses.
    Lee SH; Chu KB; Kang HJ; Quan FS
    PLoS One; 2019; 14(8):e0220865. PubMed ID: 31465461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite.
    Feliu V; Vasseur V; Grover HS; Chu HH; Brown MJ; Wang J; Boyle JP; Robey EA; Shastri N; Blanchard N
    PLoS Pathog; 2013; 9(6):e1003449. PubMed ID: 23818852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.
    Wang S; Wang Y; Sun X; Zhang Z; Liu T; Gadahi JA; Hassan IA; Xu L; Yan R; Song X; Li X
    BMC Infect Dis; 2015 Oct; 15():448. PubMed ID: 26497908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
    Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
    BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
    Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
    Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.